Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

18

Number of overlapping holdings

20.5%

% of WDNA's 91 holdings also in SYNB

51.4%

% of SYNB's 36 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus SYNB)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in SYNB
Overlap
ELI LILLY & CO 2.1% 3.7% 2.1%
TWIST BIOSCIENCE CORP. 4.3% 2.0% 2.0%
VERTEX PHARMACEUTICALS INC 1.6% 1.5% 1.5%
REGENERON PHARMACEUTICALS 1.4% 4.2% 1.4%
DANAHER CORP 1.4% 7.6% 1.4%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to SYNB
NOVOZYMES A/S-B SHARES 2.7%
BLUEPRINT MEDICINES CORP. 2.6%
GERON CORP 2.5%
AGIOS PHARMACEUTICALS INC 2.4%
TWIST BIOSCIENCE CORP. 2.3%
FATE THERAPEUTICS INC 2.2%
NATERA INC 2.2%
VERICEL CORPORATION 2.1%
IOVANCE BIOTHERAPEUTICS INC 1.7%
SAREPTA THERAPEUTICS INC 1.7%
WDNA Underweight Relative to SYNB
NVIDIA CORP -7.0%
THERMO FISHER SCIENTIFIC INC -6.7%
DANAHER CORP -6.2%
BIO-RAD LABORATORIES-CL A -5.1%
ALPHABET INC. CLASS A -5.0%
NOVOZYMES A/S-UNSPONS ADR -4.7%
ABBVIE INC -4.3%
ASCENDIS PHARMA A/S -3.5%
CORTEVA INC -3.4%
AVANTOR, INC. -3.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY